Conversely, genetic profiles showing strong GLP-1R activation typically allow more flexibility with portion sizes because the medication creates deeper fullness signals
Currently, most targeted treatments in development for LRRK2-associated PD are LRRK2 kinase inhibitors, other approaches include inhibition of GTPase activity as an indirect means of controlling LRRK2 activity, and the development of LRRK2 degraders using antisense oligonucleotide and the proteolysis targeting chimeras (PROTAC) technologies [200]
Mokrasch L.C., Teschke E.J
Orforglipron Compared With Dapagliflozin in Adults With Type 2 Diabetes and Inadequate Glycaemic Control With Metformin (ACHIEVE-2): A Multicentre, Randomised, Non-Inferiority, Open-Label, Phase 3 Trial
Remember that individual results vary, and personalization is key
Evaluation of clinical relationship of serum niacin and dopamine levels in patients with fibromyalgia syndrome